Supira Medical, founded in 2012, is a medical device company that manufactures percutaneous ventricular assist devices (pVADs) designed to give temporary mechanical support to a patient’s heart and allow them to go through required interventional procedures. The devices aim to support patients with coronary artery disease undergoing high-risk percutaneous coronary intervention as well as severe heart attack patients suffering from cardiogenic shock. Supira Medical is headquartered in Los Gatos, California.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
11/21/2023 | Series D | $40MM | $xx.xx | $292.93MM | 415 Capital, Amed Ventures, Cormorant Asset Management, Pa Medtech Vc Fund, Shifamed Angel Investors, Tcp, Unorthodox Ventures | |
Price per Share
$xx.xx
Shares Outstanding
29,585,788
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
415 Capital, Amed Ventures, Cormorant Asset Management, Pa Medtech Vc Fund, Shifamed Angel Investors, Tcp, Unorthodox Ventures
|
||||||
02/28/2022 | Series C | $30MM | $xx.xx | $252.17MM | 415 Capital, Amed Ventures, Cormorant Asset Management, Pa Medtech Vc Fund, Shifamed Angel Investors, Tcp, Unorthodox Ventures | |
Price per Share
$xx.xx
Shares Outstanding
26,666,667
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
415 Capital, Amed Ventures, Cormorant Asset Management, Pa Medtech Vc Fund, Shifamed Angel Investors, Tcp, Unorthodox Ventures
|
||||||
03/05/2020 | Series B | $35.1MM | $xx.xx | $158.01MM | 415 Capital, Amed Ventures, Cormorant Asset Management, Pa Medtech Vc Fund, Shifamed Angel Investors, Tcp, Unorthodox Ventures | |
Price per Share
$xx.xx
Shares Outstanding
47,432,419
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
415 Capital, Amed Ventures, Cormorant Asset Management, Pa Medtech Vc Fund, Shifamed Angel Investors, Tcp, Unorthodox Ventures
|
||||||
06/13/2018 | Series A | $495,000.00 | $xx.xx | $55.7MM | Cormorant Asset Management, Shifamed Angel Investors, Tcp | |
Price per Share
$xx.xx
Shares Outstanding
2,750,000
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Cormorant Asset Management, Shifamed Angel Investors, Tcp
|
||||||
06/13/2018 | Series A-1 | $15.5MM | $xx.xx | $55.7MM | Cormorant Asset Management, Shifamed Angel Investors, Tcp | |
Price per Share
$xx.xx
Shares Outstanding
35,227,261
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
--
Key Investors
Cormorant Asset Management, Shifamed Angel Investors, Tcp
|